Convergent

Investment area

Venture Investments

Region

North America

Date of investment

September 2024

Convergent Therapeutics Inc., a clinical stage biotechnology company focused on developing next generation radiopharmaceutical therapies for the treatment of prostate cancer and other cancers.

Visit site